Headline
The latest stories from AHA Today.
The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a software-related battery issue that could cause affected devices to enter Safety Mode and limit pacing…
The measles outbreak in Utah that began in June 2025 has grown to 638 cases as of May 5, according to the state’s Department of Health and Human Services.
USA Today published a column by AHA Board Chair Marc Boom, M.D., president and CEO of Houston Methodist, highlighting how hospitals and health systems continue to raise the bar and embrace innovation to advance patient safety.
The AHA shared a statement with the media in response to a report released May 7 by Families USA.
Microsoft Threat Intelligence is warning of a large scale, multistage phishing campaign that disproportionately targeted the health care sector, sending “code of conduct” themed emails to lure users into credential theft and token compromise.
The Department of Health and Human Services published an interim final rule May 7 to delay compliance dates for entities receiving federal financial assistance to comply with certain requirements under Section 504 of the Rehabilitation Act.
The AHA May 7 wrote to House and Senate lawmakers in support of the Medicare Advantage Improvement Act (H.R. 8375/S.
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible Medicare Part D beneficiaries for $50 per month beginning July 1 this year through Dec. 31, 2027.
The AHA has released new resources in celebration of National Hospital Week, which is May 10-16.
The Food and Drug Administration announced May 6 that it is aware of a shortage of neurosurgical patties, sponges and strip devices across the U.S. due to supplier issues, and expects the issue to continue through the end of the year.